An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Project Details

StatusActive
Effective start/end date16/05/1815/05/23

Funding

  • UK-based charities: £440,053.00